BCYC
Bicycle TherapeuticsCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Composite grade C from latest DB weights. Momentum 35.9 / Value 56.5
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-10-28.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
36
Value
57
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -Analysis date unavailable; returns require an exact persisted reference.
Earnings
2026-10-28
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-23 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-10-23
Investment thesis
As of 2026-10-23
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $10.14
Why
Momentum36 · Δ7d -14.0
Value57 · Δ7d -0.1
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-10-28.
- • Value remains the lead driver in the composite, 7D delta -0.1.
Contradictions & invalidation
- • Mixed signals. Wait for cleaner trend confirmation.
Catalyst clock
2026-10-28
Lead driver: Value · See fundamentals
Momentum
36
15% active weight
Current posture
7d trendSoftening
Δ7d
-14.0
Δ21d
+11.9
Value
57
85% active weight
Current posture
7d trendFlat
Δ7d
-0.1
Δ21d
-0.6
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 35.9 / Value 56.5
Fundamentals (TTM)As of 2026-10-23
Fundamentals (TTM)
As of 2026-10-23
Market Cap
$247.84M
Beta
1.64
Shares Out
50.38M
P/E (TTM) · Derived
-1.6
P/S (TTM)
16.18
P/FCF (TTM) · Derived
-1.65
Rev YoY
-78.7%
EPS YoY
-37.4%
Gross Margin
+91.4%
Op Margin
-387.5%
Net Debt
-$611.14M
Current Ratio
12.08
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data